DAPAFLOZIN M 10/1000

Dapaflozin M 10/1000 is a powerful dual-combination antidiabetic tablet used for the management of Type 2 Diabetes Mellitus. It combines:

• Dapagliflozin (10 mg) – An SGLT2 inhibitor that lowers blood sugar by enhancing glucose excretion through the urine.

• Metformin Hydrochloride (1000 mg) – A first-line biguanide agent that reduces hepatic glucose production and improves insulin sensitivity.

This combination is ideal for patients who require enhanced glycemic control when monotherapy is insufficient.

Key Benefits:

• Dual mechanism for better blood sugar control

• Supports weight loss and cardiovascular protection

• Low risk of hypoglycemia

• Once-daily dosing improves treatment adherence

• May improve HbA1c levels effectively